Imatinib
S0033 (one of the dose trials)
Novartis · Phase 3 · Terminated · Enrollment 748
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
Imatinib
Novartis · Phase 3 · Terminated · Enrollment 748
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.